世界のアーウィナーゼ市場

QYResearchが発行した調査報告書(QYR8D03557)
◆英語タイトル:Global Erwinase Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D03557
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、アーウィナーゼのグローバル市場について調査・分析し、種類別には、大腸菌、ジャガイモ黒あし病、ペグ化に、用途別には、急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他に区分してまとめました。調査対象企業は、Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech等です。

・レポートの概要
・グローバル成長トレンド
・アーウィナーゼの世界市場規模
・アーウィナーゼの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別アーウィナーゼの価格動向
・アーウィナーゼの種類別市場規模(大腸菌、ジャガイモ黒あし病、ペグ化)
・アーウィナーゼの用途別市場規模(急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他)
・アーウィナーゼの北米市場(アメリカ、カナダ、メキシコ)
・アーウィナーゼのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・アーウィナーゼのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アーウィナーゼの中南米市場(ブラジル等)
・アーウィナーゼの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・アーウィナーゼの市場規模予測
・アーウィナーゼの種類別市場予測2018-2025(大腸菌、ジャガイモ黒あし病、ペグ化)
・アーウィナーゼの用途別市場予測2018-2025(急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他)
・アーウィナーゼの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・アーウィナーゼのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・アーウィナーゼのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・アーウィナーゼの中南米市場予測2018-2025(ブラジル等)
・アーウィナーゼの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.In 2018, the global Erwinase market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Erwinase.

This study researches the market size of Erwinase, presents the global Erwinase sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Erwinase in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Erwinase for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech

Market Segment by Product Type
Escherichia coli
Erwinia Chrysanthemi
Pegylated

Market Segment by Application
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Erwinase status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Erwinase manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Erwinase are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Erwinase Market Size Growth Rate by Type
1.3.2 Escherichia coli
1.3.3 Erwinia Chrysanthemi
1.3.4 Pegylated
1.4 Market Segment by Application
1.4.1 Global Erwinase Market Share by Application (2018-2025)
1.4.2 Acute Lymphoblastic Leukemia
1.4.3 Acute Myeloid Leukemia
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Erwinase Market Size
2.1.1 Global Erwinase Revenue 2013-2025
2.1.2 Global Erwinase Sales 2013-2025
2.2 Erwinase Growth Rate by Regions
2.2.1 Global Erwinase Sales by Regions 2013-2018
2.2.2 Global Erwinase Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Erwinase Sales by Manufacturers
3.1.1 Erwinase Sales by Manufacturers 2013-2018
3.1.2 Erwinase Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Erwinase Revenue by Manufacturers (2013-2018)
3.2.2 Erwinase Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Erwinase Market Concentration Ratio (CR5 and HHI)
3.3 Erwinase Price by Manufacturers
3.4 Key Manufacturers Erwinase Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Erwinase Market
3.6 Key Manufacturers Erwinase Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Escherichia coli Sales and Revenue (2013-2018)
4.1.2 Erwinia Chrysanthemi Sales and Revenue (2013-2018)
4.1.3 Pegylated Sales and Revenue (2013-2018)
4.2 Global Erwinase Sales Market Share by Type
4.3 Global Erwinase Revenue Market Share by Type
4.4 Erwinase Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Erwinase Sales by Application

6 North America
6.1 North America Erwinase Breakdown Data by Company
6.2 North America Erwinase Breakdown Data by Type
6.3 North America Erwinase Breakdown Data by Application
6.4 North America Erwinase Breakdown Data by Countries
6.4.1 North America Erwinase Sales by Countries
6.4.2 North America Erwinase Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Erwinase Breakdown Data by Company
7.2 Europe Erwinase Breakdown Data by Type
7.3 Europe Erwinase Breakdown Data by Application
7.4 Europe Erwinase Breakdown Data by Countries
7.4.1 Europe Erwinase Sales by Countries
7.4.2 Europe Erwinase Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Erwinase Breakdown Data by Company
8.2 Asia Pacific Erwinase Breakdown Data by Type
8.3 Asia Pacific Erwinase Breakdown Data by Application
8.4 Asia Pacific Erwinase Breakdown Data by Countries
8.4.1 Asia Pacific Erwinase Sales by Countries
8.4.2 Asia Pacific Erwinase Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Erwinase Breakdown Data by Company
9.2 Central & South America Erwinase Breakdown Data by Type
9.3 Central & South America Erwinase Breakdown Data by Application
9.4 Central & South America Erwinase Breakdown Data by Countries
9.4.1 Central & South America Erwinase Sales by Countries
9.4.2 Central & South America Erwinase Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Erwinase Breakdown Data by Type
10.2 Middle East and Africa Erwinase Breakdown Data by Application
10.3 Middle East and Africa Erwinase Breakdown Data by Countries
10.3.1 Middle East and Africa Erwinase Sales by Countries
10.3.2 Middle East and Africa Erwinase Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Erwinase
11.1.4 Erwinase Product Introduction
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Erwinase
11.2.4 Erwinase Product Introduction
11.2.5 Shire Recent Development
11.3 Medac GmbH
11.3.1 Medac GmbH Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Erwinase
11.3.4 Erwinase Product Introduction
11.3.5 Medac GmbH Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Erwinase
11.4.4 Erwinase Product Introduction
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Qianhong Bio-pharma
11.5.1 Qianhong Bio-pharma Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Erwinase
11.5.4 Erwinase Product Introduction
11.5.5 Qianhong Bio-pharma Recent Development
11.6 Taj Pharmaceuticals
11.6.1 Taj Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Erwinase
11.6.4 Erwinase Product Introduction
11.6.5 Taj Pharmaceuticals Recent Development
11.7 Mingxing Pharma
11.7.1 Mingxing Pharma Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Erwinase
11.7.4 Erwinase Product Introduction
11.7.5 Mingxing Pharma Recent Development
11.8 SL Pharma
11.8.1 SL Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Erwinase
11.8.4 Erwinase Product Introduction
11.8.5 SL Pharma Recent Development
11.9 United Biotech
11.9.1 United Biotech Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Erwinase
11.9.4 Erwinase Product Introduction
11.9.5 United Biotech Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Erwinase Sales Channels
12.2.2 Erwinase Distributors
12.3 Erwinase Customers

13 Market Forecast
13.1 Global Erwinase Sales and Revenue Forecast 2018-2025
13.2 Global Erwinase Sales Forecast by Type
13.3 Global Erwinase Sales Forecast by Application
13.4 Erwinase Forecast by Regions
13.4.1 Global Erwinase Sales Forecast by Regions 2018-2025
13.4.2 Global Erwinase Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Erwinase Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Erwinase Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Erwinase Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Erwinase Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Erwinase Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアーウィナーゼ市場(Global Erwinase Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。